Skip to content
‹ Back to IndustriesHealthcare

Proven Techniques for Reining In Supply Chain Costs

Proven Techniques for Reining In Supply Chain Costs Healthcare delivery in the United States is experiencing a period of extreme flux and uncertainty that is combining to escalate costs. It is compounded by a healthcare supply chain which is vast, complex and plagued with inefficiencies. Supply costs can account for 25-30% of a hospital’s operating…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Proven Techniques for Reining In Supply Chain Costs

Healthcare delivery in the United States is experiencing a period of extreme flux and uncertainty that is combining to escalate costs. It is compounded by a healthcare supply chain which is vast, complex and plagued with inefficiencies. Supply costs can account for 25-30% of a hospital’s operating budget. Supplies relate directly to the patient experience, making it difficult to always settle for the least expensive option. Consequently, hospitals are continually faced with the challenge of decreasing supply chain costs without compromising patient care.

Supply Chain and Physician Preference Items

The balance of cost and function may be most true with Physician Preference Items (PPI) that can account for up to 60% of supply spend. As individual physicians typically select those specific tools with which they are most comfortable, PPI products can be extremely varied across the hospital. This variance, coupled with the high cost of PPI products, makes it difficult for hospital administrators to reduce spend across their organization. In order to keep supply spend in check, healthcare administrators must work collaboratively with physicians and their established preferences to address the financial bottom line and efforts to reduce costs while also improving efficiencies. It’s a collective approach among all stakeholders to balance cost, quality and outcomes.

One opportunity to significantly reduce supply chain inefficiencies and costs is through product standardization. By eliminating the number of similar products, hospitals are able to negotiate more aggressively with vendors to achieve higher value. When it comes to PPI, consideration should be made to determine which items are “preference” driven versus clinically necessary.

Standardizing physician preference items requires involving physicians in the process and educating them with clinical and financial data of clinical utilization patterns, patient outcomes, and product costs and value. While a complex and involved process, the savings extracted from a strategic focus on PPI is well worth the time and investment. TPC is a proven leader in assessing PPI opportunities, collaborating with physicians, and developing successful PPI programs that reduce supply spend without compromising clinical quality or patient care.

TPC Focus on Supply Chain and Physician Preference Items

The TPC model enables hospitals to aggregate their volume to wield increased purchasing power. By drawing upon the combined expertise of Members, TPC gives physicians, nurses, pharmacists and other clinical specialists a method to evaluate products and assess their financial value, as well as their impact on the quality of care. We have found a niche in custom contracting for high-value, complex PPI categories, such as spine and cardiology. By initiating conversations with physicians early in the process we can more effectively evaluate and analyze differences across products and vendors.

TPC collaborates with Members to create a better understanding of the market landscape and drive better decision making. Together, we level-set technology across multiple manufacturers in complex categories and drive standardization in pricing. TPC works with Clinical Value Analysis Teams (CVATs) and Physician Sub-Committees (PSCs) comprised of clinical leaders from each Member facility. These groups offer functionally equivalent, cost-effective solutions to promote a culture of clinical excellence and financial stewardship for all TPC Members. Functional equivalence is determined by objective review of the product using specific, predetermined criteria, and not based on clinical or operational preference. The members of CVATs and PSCs are of vital importance as they serve as clinical advisors, initiative champions and provide clinical input into product decisions.

Through TPC’s custom contracts, Members have achieved significant savings in multiple product categories including, $3.45 million in Cardiac Rhythm Management, $3.5 million in Spinal Implants, and $1.6 million in Interventional Cardiology. As healthcare systems across the country are seeking ways to generate cost savings in the complex category of supply chain, the TPC collaborative model has proven results in reducing supply chain expenses, especially in the challenging area of PPI.

Stronger Together. Superior Results. To learn more about TPC services for supply chain savings, visit http://www.tpc1.com/supply-chain/ today!

Read more at tpc1.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Humana's $2.8B BlackRock deal lets it buy back CenterWell clinics starting in 2028

Humana's $2.8B BlackRock deal lets it buy back CenterWell clinics starting in 2028

BlackRock's $2.8 billion buys majority ownership of a joint venture holding about 150 CenterWell clinics, replacing WCAS as Humana's outside investor. CenterWell keeps a minority stake and keeps running the clinics. The terms set a timeline: two years of expected growth spending, an option for Humana to buy clinics back from 2028, and a BlackRock right to start a sale of any clinics still in the venture at the end of 2033, with CenterWell getting the first offer. The deal is expected to close in the fourth quarter, subject to regulatory approvals.

  • 01BlackRock's $2.8 billion buys majority ownership of about 150 CenterWell clinics, while Humana keeps day-to-day management and an option to repurchase clinics starting in 2028.
  • 02The 2028 buyback and 2033 sale terms apply to the roughly 150 clinics in the new joint venture. CenterWell Senior Primary Care runs 250 clinics in total.
  • 03The deal’s lower-cost-of-capital claim will be tested after closing—first by how the venture deploys new capital over the next two years to support clinics, open locations and pursue acquisitions, and then by Humana’s 2028 decision on whether to start buying clinics back.

Nov 12, 2026

Healthcare AI should give doctors attention back, not shorter visits

Healthcare AI should give doctors attention back, not shorter visits

Healthcare organizations should deploy AI to give clinicians back attention and capacity for better decisions, not simply shorten visits. Landry argues AI should fit into existing workflows with insights appearing at the right time, and that organizations should set clear governance and automation boundaries before deployment and measure what changes for patients, clinicians and the organization.

  • 01AI success in healthcare should expand clinician capacity for thoughtful care, not optimize for visit speed; a three-minute appointment is not patient-centered innovation.
  • 02Design AI into workflows clinicians already use with insights appearing at the right moment, making adoption a workflow problem rather than a training problem.
  • 03Set automation boundaries before deploying AI, specifying what it may do alone, what it recommends for clinician decision-making, and what requires explicit human control and accountability.

Nov 11, 2026

Black Book: AI may make some outsourced health plan work cheaper to bring in-house

Black Book: AI may make some outsourced health plan work cheaper to bring in-house

U.S. health plan administrative costs rose 2.7% to about $69.2 billion in the first half of 2026, even as margins improved to 4.1%. Black Book Research's 2027 outlook says AI is starting to move payer sourcing in both directions. Demand for specialist vendors stays strong in some functions, while automation could make in-house or hybrid models viable in others. The report recommends comparing each major outsourced service with rival vendors and the best internal or hybrid option, and checking whether projected savings become actual cash.

  • 01Every major outsourced payer service should be benchmarked against a rival vendor and against the plan's best feasible internal or hybrid model, a three-way contest at each renewal.
  • 02Staffing reductions, payment recoveries, avoided vacancies and productivity improvements may not translate into recurring cash, so plans shouldn’t assume outsourcing savings can fund AI until the service, AI and funding cases are evaluated separately.
  • 03Provider data sits on both sides of the sourcing question: it is a top pain point and a specialist-demand area, yet also one of the functions where automation could make hybrid or in-house models viable.

Nov 11, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512